Pharmawide Sales (aust) Pty Ltd is a limited by shares Australian proprietary company. Located at NSW 2350 since 2014-09-22 the company is, as the updated on 2023-08-07 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2000-07-01 until 2023-07-01. Known company numbers for Pharmawide Sales (aust) Pty Ltd are as follows: ACN - 002872933, Australian Business Number - 23002872933. Their official company name changed on 2000-09-05 to Pharmawide Sales Pty Ltd. The company had used this name up until 2000-09-27. Additionally they had used Pharmawide Sales P/l from 2000-05-13 to 2000-09-05. This Australian proprietary company was previously located in NSW 2350 (from 2014-01-15 to 2014-09-22), NSW 2350 (from 2005-01-19 to 2014-01-15), NSW 2350 (from 2000-05-13 to 2005-01-19).
Status | From | To |
---|---|---|
Active | 13th May 2000 | current |
Name | From | To |
---|---|---|
Pharmawide Sales (aust) Pty Ltd | 27th September 2000 | current |
Pharmawide Sales Pty Ltd | 5th September 2000 | 27th September 2000 |
Pharmawide Sales P/l | 13th May 2000 | 5th September 2000 |
Location | From | To |
---|---|---|
NSW 2350 | 22nd September 2014 | current |
NSW 2350 | 15th January 2014 | 22nd September 2014 |
NSW 2350 | 19th January 2005 | 15th January 2014 |
NSW 2350 | 13th May 2000 | 19th January 2005 |
Status | From | To |
---|---|---|
Registered | 1st July 2000 | 1st July 2023 |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.